• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022

    5/20/22 10:02:44 AM ET
    $ALL
    $APYX
    $BILL
    $BIOL
    Property-Casualty Insurers
    Finance
    Medical/Dental Instruments
    Health Care
    Get the next $ALL alert in real time by email

    Upgrades

    For Telia Company AB (OTC:TLSNY), UBS upgraded the previous rating of Neutral to Buy. For the first quarter, Telia Company had an EPS of $0.05, compared to year-ago quarter EPS of $0.03. The stock has a 52-week-high of $9.16 and a 52-week-low of $6.76. At the end of the last trading period, Telia Company closed at $8.14.

    According to B of A Securities, the prior rating for Ollie's Bargain Outlet Holdings Inc (NASDAQ:OLLI) was changed from Underperform to Buy. In the fourth quarter, Ollie's Bargain Outlet showed an EPS of $0.69, compared to $0.97 from the year-ago quarter. At the moment, the stock has a 52-week-high of $95.43 and a 52-week-low of $37.67. Ollie's Bargain Outlet closed at $43.19 at the end of the last trading period.

    For Mirati Therapeutics Inc (NASDAQ:MRTX), Guggenheim upgraded the previous rating of Neutral to Buy. Mirati Therapeutics earned $3.40 in the first quarter, compared to $2.67 in the year-ago quarter. At the moment, the stock has a 52-week-high of $195.99 and a 52-week-low of $51.16. Mirati Therapeutics closed at $59.61 at the end of the last trading period.

    Exane BNP Paribas upgraded the previous rating for Trex Co Inc (NYSE:TREX) from Underperform to Neutral. For the first quarter, Trex Co had an EPS of $0.62, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $140.98 and a 52-week-low of $51.76. At the end of the last trading period, Trex Co closed at $61.96.

    Baird upgraded the previous rating for Comerica Inc (NYSE:CMA) from Neutral to Outperform. In the first quarter, Comerica showed an EPS of $1.37, compared to $2.43 from the year-ago quarter. At the moment, the stock has a 52-week-high of $102.09 and a 52-week-low of $63.07. Comerica closed at $72.80 at the end of the last trading period.

    See all analyst ratings upgrades.

    Downgrades

    According to Craig-Hallum, the prior rating for Citi Trends Inc (NASDAQ:CTRN) was changed from Buy to Hold. Citi Trends earned $1.16 in the fourth quarter, compared to $1.81 in the year-ago quarter. The current stock performance of Citi Trends shows a 52-week-high of $97.46 and a 52-week-low of $25.18. Moreover, at the end of the last trading period, the closing price was at $29.30.

    Argus Research downgraded the previous rating for Allstate Corp (NYSE:ALL) from Buy to Hold. In the first quarter, Allstate showed an EPS of $2.58, compared to $6.11 from the year-ago quarter. The current stock performance of Allstate shows a 52-week-high of $144.46 and a 52-week-low of $106.11. Moreover, at the end of the last trading period, the closing price was at $125.79.

    For Dollar General Corp (NYSE:DG), Gordon Haskett downgraded the previous rating of Buy to Hold. Dollar Gen earned $2.57 in the fourth quarter, compared to $2.62 in the year-ago quarter. The stock has a 52-week-high of $262.20 and a 52-week-low of $185.15. At the end of the last trading period, Dollar Gen closed at $201.33.

    According to Berenberg, the prior rating for Spero Therapeutics Inc (NASDAQ:SPRO) was changed from Buy to Hold. In the first quarter, Spero Therapeutics showed an EPS of $1.01, compared to $0.66 from the year-ago quarter. The current stock performance of Spero Therapeutics shows a 52-week-high of $19.87 and a 52-week-low of $1.38. Moreover, at the end of the last trading period, the closing price was at $1.44.

    For Pure Storage Inc (NYSE:PSTG), B of A Securities downgraded the previous rating of Buy to Neutral. In the fourth quarter, Pure Storage showed an EPS of $0.36, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $36.71 and a 52-week-low of $17.40. Pure Storage closed at $25.17 at the end of the last trading period.

    B of A Securities downgraded the previous rating for Hewlett Packard Enterprise Co (NYSE:HPE) from Buy to Neutral. Hewlett Packard earned $0.53 in the first quarter, compared to $0.52 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.76 and a 52-week-low of $12.99. Hewlett Packard closed at $15.04 at the end of the last trading period.

    According to Atlantic Equities, the prior rating for Freshpet Inc (NASDAQ:FRPT) was changed from Overweight to Neutral. In the first quarter, Freshpet showed an EPS of $0.40, compared to $0.26 from the year-ago quarter. The current stock performance of Freshpet shows a 52-week-high of $183.38 and a 52-week-low of $53.09. Moreover, at the end of the last trading period, the closing price was at $66.53.

    For Wix.com Ltd (NASDAQ:WIX), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the first quarter, Wix.com had an EPS of $0.72, compared to year-ago quarter EPS of $0.54. The stock has a 52-week-high of $309.00 and a 52-week-low of $56.24. At the end of the last trading period, Wix.com closed at $68.66.

    For Ross Stores Inc (NASDAQ:ROST), Telsey Advisory Group downgraded the previous rating of Outperform to Market Perform. Ross Stores earned $0.97 in the first quarter, compared to $1.34 in the year-ago quarter. The stock has a 52-week-high of $127.58 and a 52-week-low of $84.44. At the end of the last trading period, Ross Stores closed at $92.70.

    According to Berenberg, the prior rating for PPG Industries Inc (NYSE:PPG) was changed from Buy to Hold. PPG Indus earned $1.37 in the first quarter, compared to $1.88 in the year-ago quarter. The current stock performance of PPG Indus shows a 52-week-high of $182.97 and a 52-week-low of $111.32. Moreover, at the end of the last trading period, the closing price was at $122.67.

    See all analyst ratings downgrades.

    Initiations

    With a Buy rating, Lake Street initiated coverage on Biolase Inc (NASDAQ:BIOL). The price target seems to have been set at $12.00 for Biolase. Biolase earned $0.77 in the first quarter, compared to $1.28 in the year-ago quarter. The stock has a 52-week-high of $5.72 and a 52-week-low of $0.20. At the end of the last trading period, Biolase closed at $3.84.

    Lake Street initiated coverage on Streamline Health Solutions Inc (NASDAQ:STRM) with a Buy rating. The price target for Streamline Health Solns is set to $3.00. In the fourth quarter, Streamline Health Solns showed an EPS of $0.00, compared to $0.05 from the year-ago quarter. The current stock performance of Streamline Health Solns shows a 52-week-high of $2.29 and a 52-week-low of $1.13. Moreover, at the end of the last trading period, the closing price was at $1.22.

    Lake Street initiated coverage on Apyx Medical Corp (NASDAQ:APYX) with a Buy rating. The price target for Apyx Medical is set to $12.00. For the first quarter, Apyx Medical had an EPS of $0.17, compared to year-ago quarter EPS of $0.14. The stock has a 52-week-high of $17.50 and a 52-week-low of $3.01. At the end of the last trading period, Apyx Medical closed at $3.41.

    Evercore ISI Group initiated coverage on Inspirato Incorporated (NASDAQ:ISPO) with an In-Line rating. The price target for Inspirato is set to $6.00. At the moment, the stock has a 52-week-high of $108.00 and a 52-week-low of $4.67. Inspirato closed at $5.54 at the end of the last trading period.

    B of A Securities initiated coverage on Novavax Inc (NASDAQ:NVAX) with an Underperform rating. Novavax earned $2.56 in the first quarter, compared to $3.05 in the year-ago quarter. The current stock performance of Novavax shows a 52-week-high of $277.80 and a 52-week-low of $41.33. Moreover, at the end of the last trading period, the closing price was at $58.43.

    With an Outperform rating, Cowen & Co. initiated coverage on Leafly Holdings Inc (NASDAQ:LFLY). The price target seems to have been set at $12.00 for Leafly Holdings. The stock has a 52-week-high of $11.58 and a 52-week-low of $5.27. At the end of the last trading period, Leafly Holdings closed at $9.75.

    B of A Securities initiated coverage on TG Therapeutics Inc (NASDAQ:TGTX) with an Underperform rating. The price target for TG Therapeutics is set to $5.00. For the first quarter, TG Therapeutics had an EPS of $0.51, compared to year-ago quarter EPS of $0.69. At the moment, the stock has a 52-week-high of $41.00 and a 52-week-low of $5.51. TG Therapeutics closed at $6.04 at the end of the last trading period.

    B of A Securities initiated coverage on Revolution Medicines Inc (NASDAQ:RVMD) with a Neutral rating. The price target for Revolution Medicines is set to $24.00. For the first quarter, Revolution Medicines had an EPS of $0.78, compared to year-ago quarter EPS of $0.53. At the moment, the stock has a 52-week-high of $35.07 and a 52-week-low of $14.08. Revolution Medicines closed at $15.16 at the end of the last trading period.

    B of A Securities initiated coverage on Turning Point Therapeutics Inc (NASDAQ:TPTX) with a Buy rating. The price target for Turning Point is set to $58.00. In the first quarter, Turning Point showed an EPS of $1.50, compared to $0.73 from the year-ago quarter. At the moment, the stock has a 52-week-high of $83.06 and a 52-week-low of $23.77. Turning Point closed at $35.36 at the end of the last trading period.

    Stifel initiated coverage on ESAB Corp (NYSE:ESAB) with a Buy rating. The price target for ESAB is set to $56.00. ESAB earned $1.17 in the first quarter, compared to $1.12 in the year-ago quarter. The current stock performance of ESAB shows a 52-week-high of $58.08 and a 52-week-low of $42.96. Moreover, at the end of the last trading period, the closing price was at $46.79.

    With an Overweight rating, JP Morgan initiated coverage on Bill.com Holdings Inc (NYSE:BILL). The price target seems to have been set at $140.00 for Bill.com Holdings. For the third quarter, Bill.com Holdings had an EPS of $0.08, compared to year-ago quarter EPS of $0.02. At the moment, the stock has a 52-week-high of $348.50 and a 52-week-low of $89.87. Bill.com Holdings closed at $114.42 at the end of the last trading period.

    With a Buy rating, DA Davidson initiated coverage on SVF Investment Corp 3 (NASDAQ:SVFC). The price target seems to have been set at $15.00 for SVF Inv Corp 3. At the moment, the stock has a 52-week-high of $10.24 and a 52-week-low of $9.65. SVF Inv Corp 3 closed at $9.96 at the end of the last trading period.

    With a Neutral rating, DA Davidson initiated coverage on Coupa Software Inc (NASDAQ:COUP). The price target seems to have been set at $75.00 for Coupa Software. Coupa Software earned $0.19 in the fourth quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $283.38 and a 52-week-low of $58.43. At the end of the last trading period, Coupa Software closed at $71.73.

    Oppenheimer initiated coverage on Bentley Systems Inc (NASDAQ:BSY) with an Outperform rating. The price target for Bentley Systems is set to $40.00. In the first quarter, Bentley Systems showed an EPS of $0.24, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $71.92 and a 52-week-low of $26.32. At the end of the last trading period, Bentley Systems closed at $32.29.

    See all analyst ratings initiations.

    Get the next $ALL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALL
    $APYX
    $BILL
    $BIOL

    CompanyDatePrice TargetRatingAnalyst
    Trex Company Inc.
    $TREX
    2/11/2026Buy → Hold
    The Benchmark Company
    BILL Holdings Inc.
    $BILL
    2/6/2026$50.00 → $46.00Market Perform
    BMO Capital Markets
    Bentley Systems Incorporated
    $BSY
    1/22/2026$48.00Outperform
    BMO Capital Markets
    Hewlett Packard Enterprise Company
    $HPE
    1/13/2026$31.00Buy
    Goldman
    Bentley Systems Incorporated
    $BSY
    1/13/2026$45.00Overweight → Neutral
    Piper Sandler
    Allstate Corporation
    $ALL
    1/12/2026$231.00Buy → Hold
    TD Cowen
    Trex Company Inc.
    $TREX
    1/12/2026$50.00Neutral → Buy
    DA Davidson
    Ross Stores Inc.
    $ROST
    1/8/2026Buy
    Deutsche Bank
    More analyst ratings

    $ALL
    $APYX
    $BILL
    $BIOL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Financial Officer Gandhi Prithvi bought $478,840 worth of shares (15,000 units at $31.92), increasing direct ownership by 96% to 30,664 units (SEC Form 4)

    4 - TREX CO INC (0001069878) (Issuer)

    11/17/25 8:51:47 AM ET
    $TREX
    Forest Products
    Basic Materials

    SVP, CHRO Rudolph Jacob T. bought $2,591 worth of shares (59 units at $43.92), increasing direct ownership by 0.21% to 27,652 units (SEC Form 4)

    4 - TREX CO INC (0001069878) (Issuer)

    10/14/25 12:54:39 PM ET
    $TREX
    Forest Products
    Basic Materials

    Director George Walter N. bought $52,570 worth of shares (1,000 units at $52.57), increasing direct ownership by 2% to 46,527 units (SEC Form 4)

    4 - Freshpet, Inc. (0001611647) (Issuer)

    9/18/25 6:19:40 PM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    $ALL
    $APYX
    $BILL
    $BIOL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman Swygert John W sold $126,180 worth of shares (1,126 units at $112.06), decreasing direct ownership by 2% to 48,200 units (SEC Form 4)

    4 - Ollie's Bargain Outlet Holdings, Inc. (0001639300) (Issuer)

    2/11/26 4:30:20 PM ET
    $OLLI
    Department/Specialty Retail Stores
    Consumer Discretionary

    Officer Goldsmith Mark A exercised 24,010 shares at a strike of $0.54, increasing direct ownership by 10% to 256,479 units (SEC Form 4)

    4 - Revolution Medicines, Inc. (0001628171) (Issuer)

    2/10/26 5:30:31 PM ET
    $RVMD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Officer Rajavelu Esther sold $207,484 worth of shares (87,917 units at $2.36), decreasing direct ownership by 8% to 1,012,091 units (SEC Form 4)

    4 - Spero Therapeutics, Inc. (0001701108) (Issuer)

    2/9/26 9:31:37 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALL
    $APYX
    $BILL
    $BIOL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dollar General Corporation Announces Webcast of its Fourth Quarter 2025 Earnings Conference Call

    Dollar General Corporation (NYSE:DG) today announced that it plans to release its financial results for the fiscal 2025 fourth quarter and full year ended January 30, 2026, on March 12, 2026. In connection with the release, Todd Vasos, chief executive officer, and Donny Lau, chief financial officer, will host a conference call on March 12, 2026, at 8:00 a.m. CT/9:00 a.m. ET. During the call, the company will discuss the earnings results and may discuss material business, financial or other information that is not contained in the earnings release. To participate via telephone, please call (877) 407-0890 at least 10 minutes before the conference call is scheduled to begin. The conferen

    2/12/26 6:55:00 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    Trex® Named "America's Most Trusted® Outdoor Decking"

    WINCHESTER, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Trust isn't given – it's earned, year after year. Trex®, the world's #1 brand of wood-alternative composite decking and deck railing, has once again been named "2026 America's Most Trusted® Outdoor Decking," by Lifestory Research. The recognition marks the sixth consecutive year the brand has earned top honors in its category. "For homeowners making long-term investments in their homes and outdoor spaces, trust matters," said Jodi Lee, Senior Vice President of Marketing for Trex. "Over the past 30+ years, Trex has built a legacy of trust with our customers by consistently delivering industry-leading products and an unwavering commitment t

    2/11/26 8:30:00 AM ET
    $TREX
    Forest Products
    Basic Materials

    New Research Finds Only 5% of Enterprises are Fully Ready for The Great Virtualization Reset

    HPE survey reveals that more than two thirds of enterprises are planning material changes to their virtualization strategy within the next two years as pressure mounts from AI, cost uncertainty, and performance demands. In this article: Next 12-24 months marks an inflection point for virtualization as enterprises move from planning to active transformation AI readiness–not solely virtualization licensing costs–is the primary force reshaping strategies in favor of a flexible, hybrid operating model Security, observability, and data protection rise as essential pillars of modern virtualization As AI increases operational complexity and cloud costs, enterprises are rethinking whe

    2/10/26 9:00:00 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ALL
    $APYX
    $BILL
    $BIOL
    SEC Filings

    View All

    SEC Form 15-12G filed by Comerica Incorporated

    15-12G - COMERICA INC (0000028412) (Filer)

    2/12/26 7:07:03 AM ET
    $CMA
    Major Banks
    Finance

    SEC Form 15-12G filed by Comerica Incorporated

    15-12G - COMERICA INC (0000028412) (Filer)

    2/12/26 7:04:43 AM ET
    $CMA
    Major Banks
    Finance

    SEC Form DEFA14A filed by Hewlett Packard Enterprise Company

    DEFA14A - Hewlett Packard Enterprise Co (0001645590) (Filer)

    2/11/26 4:11:59 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ALL
    $APYX
    $BILL
    $BIOL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ALL
    $APYX
    $BILL
    $BIOL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Trex downgraded by The Benchmark Company

    The Benchmark Company downgraded Trex from Buy to Hold

    2/11/26 6:57:04 AM ET
    $TREX
    Forest Products
    Basic Materials

    BMO Capital Markets reiterated coverage on Bill.com with a new price target

    BMO Capital Markets reiterated coverage of Bill.com with a rating of Market Perform and set a new price target of $46.00 from $50.00 previously

    2/6/26 6:48:02 AM ET
    $BILL
    EDP Services
    Technology

    BMO Capital Markets initiated coverage on Bentley Systems with a new price target

    BMO Capital Markets initiated coverage of Bentley Systems with a rating of Outperform and set a new price target of $48.00

    1/22/26 8:28:24 AM ET
    $BSY
    Computer Software: Prepackaged Software
    Technology

    $ALL
    $APYX
    $BILL
    $BIOL
    Leadership Updates

    Live Leadership Updates

    View All

    Trex Company Appoints Irene Tasi to Board of Directors

    Trex Company, Inc. (NYSE:TREX), the world's largest manufacturer of wood-alternative decking and railing, today announced the appointment of Irene Tasi as a new independent member of its Board of Directors, effective immediately. Ms. Tasi brings more than 25 years of leadership experience across the global industrial and building product sectors, with particular expertise in strategic development and transformation. She currently serves as Chief Transformation Officer at PPG, a global manufacturer and distributor of paints, coatings, and specialty products, where she leads enterprise-wide transformation and growth initiatives. During her tenure at PPG, Ms. Tasi has also served as Senior V

    2/9/26 4:10:00 PM ET
    $TREX
    Forest Products
    Basic Materials

    Freshpet Strengthens Leadership Team with Strategic Appointments Across Finance and Supply Chain

    Appoints John O'Connor as Chief Financial Officer Appoints Ana Lopez as Senior Vice President Supply ChainCompany Reaffirms Full Year 2025 Outlook BEDMINSTER, N.J, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Freshpet, Inc. ("Freshpet" or the "Company") (NASDAQ:FRPT) today announced the appointment of John O'Connor as Chief Financial Officer, effective February 9, 2026, and Ana Lopez as Senior Vice President of Supply Chain, effective February 2, 2026. Mr. O'Connor succeeds Ivan Garcia, who has served as Interim Chief Financial Officer since October 2025 and will continue with the Company as Senior Vice President of Finance. Mr. O'Connor will report to Chief Executive Officer Billy Cyr, and Ms. Lope

    2/4/26 8:00:00 AM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Eddyfi Technologies Announces Signing of Definitive Agreement to join ESAB

    QUEBEC CITY, Feb. 2, 2026 /CNW/ - Eddyfi Technologies, a global leader in advanced non-destructive testing and integrity management technologies and solutions, is pleased to announce that it has entered into a definitive agreement to join ESAB, a focused premier industrial compounder. The transaction, valued at US$1.45 billion or C$2.0 billion in cash for 100 percent of the outstanding shares of the company, is subject to customary regulatory approvals and closing conditions and is expected to close later in 2026. This announcement marks an important milestone following the sp

    2/2/26 1:07:00 PM ET
    $ESAB
    Industrial Machinery/Components
    Industrials

    $ALL
    $APYX
    $BILL
    $BIOL
    Financials

    Live finance-specific insights

    View All

    Dollar General Corporation Announces Webcast of its Fourth Quarter 2025 Earnings Conference Call

    Dollar General Corporation (NYSE:DG) today announced that it plans to release its financial results for the fiscal 2025 fourth quarter and full year ended January 30, 2026, on March 12, 2026. In connection with the release, Todd Vasos, chief executive officer, and Donny Lau, chief financial officer, will host a conference call on March 12, 2026, at 8:00 a.m. CT/9:00 a.m. ET. During the call, the company will discuss the earnings results and may discuss material business, financial or other information that is not contained in the earnings release. To participate via telephone, please call (877) 407-0890 at least 10 minutes before the conference call is scheduled to begin. The conferen

    2/12/26 6:55:00 AM ET
    $DG
    Department/Specialty Retail Stores
    Consumer Discretionary

    BILL Reports Second Quarter Fiscal Year 2026 Financial Results

    Q2 Core Revenue Increased 17% Year-Over-Year Q2 Total Revenue Increased 14% Year-Over-Year BILL (NYSE:BILL), the intelligent finance platform trusted by half a million businesses to manage, move and maximize their money, today announced financial results for the second fiscal quarter ended December 31, 2025. "We delivered a strong Q2, with a significant beat on revenue and profitability, and continued our track record of rapid innovation," said René Lacerte, BILL CEO and Founder. "With a leading position in a large market, strong brand recognition, and a differentiated platform and distribution ecosystem, we are leveraging our unique assets alongside AI to eliminate unnecessary wor

    2/5/26 4:01:00 PM ET
    $BILL
    EDP Services
    Technology

    Allstate Enhances Customer Value, Lowers Prices for 7.8 Million Customers in 2025

    NORTHBROOK, Ill., Feb. 4, 2026 /PRNewswire/ -- The Allstate Corporation (NYSE:ALL) today reported financial results for the fourth quarter of 2025. "Allstate had a terrific year by better serving customers and making protection more affordable," said Tom Wilson, who leads The Allstate Corporation. "We proactively reduced premiums for 7.8 million auto and homeowners insurance customers by an average of 17% through tailored coverage reviews to offset cost inflation. We also improved 69 million customer interactions and provided customers with nearly $38 billion in support and fi

    2/4/26 5:31:00 PM ET
    $ALL
    Property-Casualty Insurers
    Finance

    $ALL
    $APYX
    $BILL
    $BIOL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Citi Trends Inc.

    SC 13G/A - Citi Trends Inc (0001318484) (Subject)

    12/6/24 4:29:10 PM ET
    $CTRN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Citi Trends Inc.

    SC 13G/A - Citi Trends Inc (0001318484) (Subject)

    12/6/24 4:22:55 PM ET
    $CTRN
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by TG Therapeutics Inc.

    SC 13G/A - TG THERAPEUTICS, INC. (0001001316) (Subject)

    11/14/24 7:45:34 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care